Yungjin Pharm. Co., Ltd. (003520.KS)
KRW 1989.0
(-2.02%)
KRW 1989.0
(-2.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.49 Billion | -11.6 Billion | 8.36 Billion | 14.49 Billion | 9.28 Billion | 1.27 Billion |
| Net Income | -3.87 Billion | -21.96 Billion | -11.58 Billion | -133.12 Million | 5.02 Billion | -6.1 Billion |
| Depreciation & Amortization | 8.69 Billion | 7.77 Billion | 7.37 Billion | 7.78 Billion | 7.64 Billion | 6.64 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -27.07 Billion | -21.51 Billion | -314.63 Million | 1.74 Billion | -14.04 Billion | -6.04 Billion |
| Other non-cash items | 9.75 Billion | 24.08 Billion | 12.88 Billion | 5.1 Billion | 10.65 Billion | 6.77 Billion |
| Investing Cash Flow | -13.01 Billion | -13.35 Billion | -11.63 Billion | -5.65 Billion | -10.33 Billion | 2.62 Billion |
| Investments in PPE | -10.23 Billion | -13.2 Billion | -11.31 Billion | -6.3 Billion | -10.35 Billion | -4.7 Billion |
| Acquisitions | 58.52 Million | 65.12 Million | -66.59 Million | 78.12 Million | 32.25 Million | 287.69 Million |
| Investment purchases | -8 Billion | - | -499.99 Million | - | -32.25 Million | -31 Billion |
| Sales/Maturities of investments | 5 Billion | - | 357 Thousand | - | 3 Million | 39 Billion |
| Other Investing Activities | 153.48 Million | -217.3 Million | 248.38 Million | 573.98 Million | 18.63 Million | -952.19 Million |
| Financing Cash Flow | 32.04 Billion | 25.17 Billion | 3.3 Billion | -9.06 Billion | -128.29 Million | -6.25 Billion |
| Debt repayment | -33.21 Billion | -103.98 Billion | -52.68 Billion | -69.41 Billion | -89.91 Billion | -63.37 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 65.26 Billion | 129.16 Billion | 55.99 Billion | 60.34 Billion | 89.78 Billion | 57.11 Billion |
| Accounts receivables | -1.2 Billion | -3.28 Billion | -3.13 Billion | 5.84 Billion | 7.71 Billion | -563.21 Million |
| Accounts payables | -3.11 Billion | 7.15 Billion | 2.99 Billion | -2.41 Billion | -4.77 Billion | 7.25 Billion |
| Inventory | -14.45 Billion | -13.13 Billion | 3.04 Billion | 1.75 Billion | -10.84 Billion | -8.31 Billion |
| Other working capital | -8.3 Billion | -12.25 Billion | -3.21 Billion | -3.44 Billion | -6.13 Billion | 2.26 Billion |
| Cash at beginning of period | 682.25 Million | 464.57 Million | 427.68 Million | 651.87 Million | 1.83 Billion | 4.18 Billion |
| Cash at end of period | 7.2 Billion | 682.25 Million | 464.57 Million | 427.68 Million | 651.87 Million | 1.83 Billion |
| Capital Expenditure | -10.23 Billion | -13.2 Billion | -11.31 Billion | -6.3 Billion | -10.35 Billion | -4.7 Billion |
| Effect of forex changes on cash | - | - | 10.00 | -3.39 Million | 10.00 | 3.35 Million |
| Net cash flow / Change in cash | 6.52 Billion | 217.68 Million | 36.88 Million | -224.18 Million | -1.18 Billion | -2.35 Billion |
| Free Cash Flow | -22.73 Billion | -24.8 Billion | -2.95 Billion | 8.19 Billion | -1.07 Billion | -3.43 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.45 Billion | 4.09 Billion | -3.87 Billion | -1.16 Billion | -875.57 Million | -1.68 Billion |
| Depreciation & Amortization | 2.16 Billion | 2.18 Billion | 8.69 Billion | 2.14 Billion | 2.14 Billion | 2.19 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 2.01 Billion | 160.71 Million | -27.07 Billion | -8.58 Billion | -10.53 Billion | 790.4 Million |
| Other non-cash items | 7.37 Billion | 5.49 Billion | 9.75 Billion | 4.14 Billion | 2.13 Billion | 1.95 Billion |
| Investing Cash Flow | -4.77 Billion | -5.23 Billion | -13.01 Billion | -7.66 Billion | -1.14 Billion | -2.24 Billion |
| Investments in PPE | -4.8 Billion | -3.18 Billion | -10.23 Billion | -4.66 Billion | -1.35 Billion | -2.23 Billion |
| Acquisitions | - | - | 58.52 Million | 1.2 Million | 47.55 Million | 4.22 Million |
| Investment purchases | -10 Billion | -10 Billion | -8 Billion | -8 Billion | - | -6.22 Million |
| Sales/Maturities of investments | 10 Billion | 8 Billion | 5 Billion | 5 Billion | - | 2 Million |
| Other Investing Activities | 26.94 Million | -49.92 Million | 153.48 Million | 20.00 | 166.67 Million | -6.39 Million |
| Financing Cash Flow | -1.52 Billion | -1.52 Billion | 32.04 Billion | 16.82 Billion | 8.37 Billion | 106.62 Million |
| Debt repayment | -1.25 Billion | -1.25 Billion | -33.21 Billion | -17.09 Billion | -16.75 Billion | -16.5 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -279.65 Million | - | 65.26 Billion | 33.92 Billion | 25.12 Billion | 16.6 Billion |
| Accounts receivables | 959.27 Million | 1.9 Billion | -1.2 Billion | 369.9 Million | -4.83 Billion | 2.16 Billion |
| Accounts payables | 751.56 Million | 3.04 Billion | -3.11 Billion | -4.85 Billion | 344.22 Million | 3.01 Billion |
| Inventory | -1.63 Billion | -2.35 Billion | -14.45 Billion | 20.66 Million | -4.48 Billion | -4.94 Billion |
| Other working capital | 1.94 Billion | -2.43 Billion | -8.3 Billion | -4.11 Billion | -1.56 Billion | 553.13 Million |
| Cash at beginning of period | 10.6 Billion | 7.2 Billion | 682.25 Million | 1.5 Billion | 1.39 Billion | 275.22 Million |
| Cash at end of period | 10.14 Billion | 10.6 Billion | 7.2 Billion | 7.2 Billion | 1.5 Billion | 1.39 Billion |
| Capital Expenditure | -4.8 Billion | -3.18 Billion | -10.23 Billion | -4.66 Billion | -1.35 Billion | -2.23 Billion |
| Effect of forex changes on cash | - | - | - | - | -130.00 | 120.00 |
| Net cash flow / Change in cash | -468.96 Million | 3.4 Billion | 6.52 Billion | 5.7 Billion | 104.16 Million | 1.12 Billion |
| Free Cash Flow | 1.03 Billion | 6.97 Billion | -22.73 Billion | -8.12 Billion | -8.48 Billion | 1.02 Billion |
2441
BHAC
TRVI
THYAO
6115
ACLIF